stock

Illumina Inc (ILMN)

Share

Stay up to date

at illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. these studies will help make the realization of personalized medicine possible. with such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. as a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. illumina’s innovative, array-based solutions for dna, rna, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.

Financial Statements

Key Info

  • Industry: Analytical Laboratory Instrument Manufacturing
  • Sector: Manufacturing
  • CEO Name: Francis deSouza

Key Statistics

  • Stock Price: $139.78
  • Dividend Yield: 0%
  • Market Capitalization: $22,401,722,000
  • Shares Outstanding: 158,900,000
  • Number of Employees: 10,007
  • Trailing 12-Month EPS: $-7.35
  • Trailing 12-Month DPS: $0
  • Payout Ratio: -0.0%

Important Dates

  • Next Earnings Date: 2024-04-30
  • Next Ex-Dividend Date:

Price Trends

  • Current Stock Price: $139.78
  • 52-week high: $238.55
  • 52-week low: $89
  • 200-day moving average: $133.37
  • 50-day moving average: $140.2

Performance

  • 1-Month Price Return: 0.2%
  • 3-Month Price Return: 46.0%
  • 6-Month Price Return: -10.9%
  • 1-Year Price Return: -28.4%
  • 2-Year Price Return: -57.2%
  • 5-Year Price Return: -54.4%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast